Grant: Operating Grant: Fall 2008 Priority Announcement (IMHA)
University of Toronto
$91,870.00
A calreticulin-cytomechanical switch in osteoblast-adipocyte fate choice in an ES cell model
EF 2008-09
Résumé
Work from several laboratories has demonstrated that cell shape, cytoskeletal tension and substratum compliance direct differentiation in many cell types including ES cells. Calreticulin, a Ca-binding chaperone either by its role in intracellular Ca homeostasis or as a chaperone, modulates actions of tissue-specific transcription factors and signalling pathways that control cell lineage specification and expression of the differentiated phenotype. The growth substratum also influences the expression of the differentiated phenotype by affecting the cell adhesion and shape, which are modulated by calreticulin. Thus, both cell shape and signalling pathways are affected by calreticulin expression level. Consequently, we postulate that the cell fate choice is controlled by the combinatorial action of calreticulin level of expression and biomechanics of the substratum.
While the role of calreticulin in adipogenesis and cardiomyogenesis from ES cells has been established, its role in skeletogenesis is not yet clear. In the present proposal, we thus wish to first elucidate the role of calreticulin in osteogenic differentiation of ES cells. Next, we will elucidate the role of substratum biomechanics in directing ES cell differentiation in the presence or absence of calreticulin.
These experiments will allow us to delineate the role of calreticulin in mesenchymal cell differentiation from ES cells and will address the emerging question of the impact of the biomechanics of the environment on cell fate. The results may have important implications for tissue engineering and regenerative medicine.
Programme
Operating Grant: Fall 2008 Priority Announcement (IMHA)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
179201
Name
Opas Michal J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
A calreticulin-cytomechanical switch in osteoblast-adipocyte fate choice in an ES cell model
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$91,870
Cihrequipment2
$0
Programname2
Operating Grant: Fall 2008 Priority Announcement (IMHA)
Keyworddelim
Ca Binding Proteins; Chondro/Osteogenesis; Development
Abstract
Work from several laboratories has demonstrated that cell shape, cytoskeletal tension and substratum compliance direct differentiation in many cell types including ES cells. Calreticulin, a Ca-binding chaperone either by its role in intracellular Ca homeostasis or as a chaperone, modulates actions of tissue-specific transcription factors and signalling pathways that control cell lineage specification and expression of the differentiated phenotype. The growth substratum also influences the expression of the differentiated phenotype by affecting the cell adhesion and shape, which are modulated by calreticulin. Thus, both cell shape and signalling pathways are affected by calreticulin expression level. Consequently, we postulate that the cell fate choice is controlled by the combinatorial action of calreticulin level of expression and biomechanics of the substratum.
While the role of calreticulin in adipogenesis and cardiomyogenesis from ES cells has been established, its role in skeletogenesis is not yet clear. In the present proposal, we thus wish to first elucidate the role of calreticulin in osteogenic differentiation of ES cells. Next, we will elucidate the role of substratum biomechanics in directing ES cell differentiation in the presence or absence of calreticulin.
These experiments will allow us to delineate the role of calreticulin in mesenchymal cell differentiation from ES cells and will address the emerging question of the impact of the biomechanics of the environment on cell fate. The results may have important implications for tissue engineering and regenerative medicine.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Opas, Michal J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $91,870~ $0~